PPioneerautohub

Losartan Drug Interactions: What Active People Should Know

Editorial Team · Section: Organ Protection: Medications · Reading time: 7 min
Losartan Drug Interactions: What Active People Should Know
Photo: Zulfugar Karimov / Unsplash

Losartan is one of the most widely prescribed blood pressure medications in the United States, and many people who take it also train, use supplements or reach for over-the-counter painkillers. Some of these combinations are harmless; others can affect the kidneys or blood potassium. Our editorial team reviews the interactions that matter most.

How Losartan Works and Why Interactions Happen

Losartan belongs to the angiotensin II receptor blockers (ARBs). It blocks the AT1 receptor, preventing angiotensin II from constricting blood vessels and stimulating aldosterone release. The result is lower blood pressure and reduced strain on the heart and kidneys.

After oral intake, losartan is converted in the liver, mainly by the enzymes CYP2C9 and CYP3A4, into an active metabolite called E-3174, which is considerably more potent and longer acting than the parent drug. Sica and colleagues (2005) described this pharmacokinetic pathway in detail.

Interactions occur through two main routes. Pharmacodynamic interactions involve drugs that also affect blood pressure, kidney blood flow or potassium. Pharmacokinetic interactions involve drugs that change how losartan is metabolized into its active form.

Because ARBs lower aldosterone activity, the body retains slightly more potassium. In most people this is clinically insignificant, but combined with other potassium-raising factors it can lead to hyperkalemia, a condition that can disturb heart rhythm.

NSAIDs and the "Triple Whammy"

Nonsteroidal anti-inflammatory drugs such as ibuprofen and naproxen are sold over the counter and are common among athletes dealing with sore joints. They reduce prostaglandins that help maintain blood flow to the kidneys, which can blunt the blood pressure-lowering effect of losartan.

The more serious concern is acute kidney injury. A large nested case-control study by Lapi and colleagues (2013) in the BMJ found that combining an NSAID with both a diuretic and an ACE inhibitor or ARB was associated with a significantly higher risk of acute kidney injury, especially in the first weeks of use.

Dehydration amplifies the problem. A long run or hot-weather training session, sweating heavily, and then taking ibuprofen while on losartan and a diuretic is precisely the scenario clinicians warn about.

Losartan alone + NSAID + NSAID + diuretic + all three + dehydration Relative risk level (schematic)
Fig. 1. Schematic illustration of how kidney injury risk tends to rise as interacting factors accumulate (illustrative, not study figures).

Acetaminophen is often suggested as an alternative for occasional pain, though it has its own limits and liver considerations. Any regular painkiller use should be discussed with the prescribing physician.

Losartan Drug Interactions: What Active People Should Know — illustration
Photo: Brecht Corbeel / Unsplash

Potassium, Salt Substitutes and Diuretics

Potassium supplements, potassium-sparing diuretics (spironolactone, eplerenone, amiloride, triamterene) and potassium-based salt substitutes can all add to the potassium-retaining effect of losartan. The FDA-approved labeling for losartan (Cozaar) specifically warns about these combinations.

Some electrolyte drinks and "lite" salts contain meaningful amounts of potassium chloride. For most healthy people with normal kidneys this is not a problem, but in combination with an ARB and reduced kidney function it can matter.

Thiazide diuretics such as hydrochlorothiazide are frequently combined with losartan in a single pill. They tend to lower potassium, partly balancing the ARB effect, but they increase fluid and sodium loss — relevant for endurance athletes who sweat heavily.

Routine blood tests for potassium and creatinine after starting or adjusting therapy are standard practice. Athletes should be aware that creatine supplementation can raise serum creatinine without true kidney damage, so it is worth telling the doctor about it before lab work.

Other Clinically Important Interactions

Interacting drug or substancePossible effectTypical clinical approach
ACE inhibitors, aliskiren (dual RAAS blockade)Higher risk of hyperkalemia, low blood pressure, kidney injuryGenerally avoided; aliskiren contraindicated in diabetes
LithiumIncreased lithium levels and toxicityClose monitoring of lithium levels
Fluconazole and other CYP2C9 inhibitorsReduced conversion to active metaboliteClinical monitoring of blood pressure
Rifampin (enzyme inducer)Lower levels of losartan and E-3174Dose review by physician
Stimulant pre-workouts, decongestantsCounteract blood pressure controlAvoid or discuss with doctor
AlcoholAdditive blood pressure lowering, dizzinessModeration

Dual blockade of the renin-angiotensin system was tested in large trials. ONTARGET (2008) found that combining telmisartan with ramipril did not improve outcomes but increased adverse events, and VA NEPHRON-D (2013) was stopped early because combined therapy raised hyperkalemia and kidney injury.

Kazierad and colleagues (1997) showed that fluconazole changes losartan pharmacokinetics, reducing formation of the active metabolite. The clinical consequence is usually modest, but it illustrates why the full medication list matters.

Pre-workout supplements containing high doses of caffeine, synephrine or yohimbine can raise blood pressure and heart rate. They do not interact with losartan chemically, but they work in the opposite direction of the therapy.

Practical Safety Checklist

  1. Keep an up-to-date list of all medications, supplements and sports products and share it with every prescriber and pharmacist.
  2. Ask before using NSAIDs regularly, especially if you also take a diuretic.
  3. Avoid potassium supplements and potassium-based salt substitutes unless your doctor approves them.
  4. Stay well hydrated around long or hot training sessions; illness with vomiting or diarrhea may require temporary medication review.
  5. Report dizziness, muscle weakness, palpitations or a sharp drop in urine output promptly.

Losartan is contraindicated in pregnancy because drugs acting on the renin-angiotensin system can harm the developing fetus. Women of reproductive age should discuss contraception and pregnancy plans with their physician.

Regular exercise itself is beneficial for people with hypertension and often allows better blood pressure control. The goal is not to avoid activity, but to combine it intelligently with medication.

Pharmacists in the US can run interaction checks at no cost when filling a prescription. Using a single pharmacy for all prescriptions makes these checks more reliable.

Important. This article is for informational purposes only and does not replace advice from your physician or pharmacist. Losartan is a prescription medication; never start, stop or combine it with other drugs or supplements without medical supervision.

Editorial Team Conclusions

Losartan is generally well tolerated, but its interactions with NSAIDs, diuretics, potassium sources, lithium and other RAAS blockers can have real consequences for the kidneys and heart rhythm.

For active people, the most practical risks are combining painkillers with dehydration and using stimulant supplements that work against blood pressure control. Transparent communication with the care team prevents most problems.

Readers may also find useful our articles on the history of losartan, how NSAIDs affect the kidneys in endurance athletes, and what blood tests to monitor when taking blood pressure medication.

References

  1. Sica DA, Gehr TW, Ghosh S. Clinical pharmacokinetics of losartan. Clin Pharmacokinet. 2005;44(8):797–814.
  2. Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ. 2013;346:e8525.
  3. ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547–1559.
  4. Fried LF, Emanuele N, Zhang JH, et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med. 2013;369(20):1892–1903.
  5. Kazierad DJ, Martin DE, Blum RA, et al. Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteers. Clin Pharmacol Ther. 1997;62(4):417–425.
  6. Cozaar (losartan potassium) tablets. US prescribing information. Merck Sharp & Dohme.
© 2026 PioneerautohubPioneerautohub